Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Troels Yndigegn"'
Autor:
Sofia Cederström, Pia Lundman, Joakim Alfredsson, Emil Hagström, Annica Ravn-Fischer, Stefan Söderberg, Troels Yndigegn, Per Tornvall, Tomas Jernberg
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Despite abundant knowledge about the relationship between inflammation and coronary atherosclerosis, it is still unknown whether systemic inflammation measured as high-sensitivity C-reactive protein (hsCRP) is associated with coronary athero
Externí odkaz:
https://doaj.org/article/3d1f793bb977408a9905683d6f30c1a2
Autor:
Karolina Berntorp, Rebecca Rylance, Troels Yndigegn, Sasha Koul, Ole Fröbert, Evald H. Christiansen, David Erlinge, Matthias Götberg
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 3 (2023)
Background Although physiology‐based assessment of coronary artery stenosis using instantaneous wave‐free ratio (iFR) and fractional flow reserve (FFR) are established methods of guiding coronary revascularization, its clinical outcome in long‐
Externí odkaz:
https://doaj.org/article/7c4a14efd9ed48d99e7172c2c5d0ee09
Autor:
Per Tornvall, Eva Swahn, Dimitrios Venetsanos, Troels Yndigegn, Sofia Sederholm Lawesson, Lena Jonasson, Nina Johnston, Henrik Wilander, Christos Pagonis, Christian Dworeck, Thomas Kellerth
Publikováno v:
BMJ Open, Vol 12, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/5067f38299a841fd957960cbeed12fbb
Autor:
Moman A. Mohammad, Jonas Persson, Sergio Buccheri, Jacob Odenstedt, Giovanna Sarno, Oskar Angerås, Sebastian Völz, Tim Tödt, Matthias Götberg, Nazim Isma, Troels Yndigegn, Patrik Tydén, Dimitrios Venetsanos, Mats Birgander, Göran K. Olivecrona
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 7 (2022)
Background The use of percutaneous coronary intervention (PCI) to treat unprotected left main coronary artery disease has expanded rapidly in the past decade. We aimed to describe nationwide trends in clinical practice and outcomes after PCI for left
Externí odkaz:
https://doaj.org/article/de9ccca960cb40749dc98665137a3081
Autor:
Robin Hofmann, Tamrat Befekadu Abebe, Johan Herlitz, Stefan K. James, David Erlinge, Troels Yndigegn, Joakim Alfredsson, Thomas Kellerth, Annica Ravn-Fischer, Sebastian Völz, Jörg Lauermann, Tomas Jernberg, Bertil Lindahl, Sophie Langenskiöld
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: After decades of ubiquitous oxygen therapy in all patients with acute myocardial infarction (MI), recent guidelines are more restrictive based on lack of efficacy in contemporary trials evaluating hard clinical outcomes in patients withou
Externí odkaz:
https://doaj.org/article/2465091543e740f9a5d52c0ce15c5c43
Autor:
Karolina Berntorp, Rebecca Rylance, Troels Yndigegn, Sasha Koul, Ole Fröbert, Evald H. Christiansen, David Erlinge, Matthias Götberg
Publikováno v:
Berntorp, K, Rylance, R, Yndigegn, T, Koul, S, Fröbert, O, Christiansen, E H, Erlinge, D & Götberg, M 2023, ' Clinical Outcome of Revascularization Deferral With Instantaneous Wave-Free Ratio and Fractional Flow Reserve : A 5-Year Follow-Up Substudy From the iFR-SWEDEHEART Trial ', Journal of the American Heart Association, vol. 12, no. 3, e028423 . https://doi.org/10.1161/JAHA.122.028423
Background Although physiology-based assessment of coronary artery stenosis using instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR) are established methods of guiding coronary revascularization, its clinical outcome in long-term d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::735cb434e1ae6a409baf9f25cda61b0d
https://pure.au.dk/portal/da/publications/clinical-outcome-of-revascularization-deferral-with-instantaneous-wavefree-ratio-and-fractional-flow-reserve(d6a5c0d3-93f3-461f-8b35-6e64b38b39de).html
https://pure.au.dk/portal/da/publications/clinical-outcome-of-revascularization-deferral-with-instantaneous-wavefree-ratio-and-fractional-flow-reserve(d6a5c0d3-93f3-461f-8b35-6e64b38b39de).html
Autor:
Matthias Götberg, Karolina Berntorp, Rebecca Rylance, Evald H. Christiansen, Troels Yndigegn, Ingibjörg J. Gudmundsdottir, Sasha Koul, Lennart Sandhall, Mikael Danielewicz, Lars Jakobsen, Sven-Erik Olsson, Hans Olsson, Elmir Omerovic, Fredrik Calais, Pontus Lindroos, Michael Maeng, Dimitrios Venetsanos, Stefan K. James, Amra Kåregren, Jörg Carlsson, Jens Jensen, Ann-Charlotte Karlsson, David Erlinge, Ole Fröbert
Publikováno v:
Götberg, M, Berntorp, K, Rylance, R, Christiansen, E H, Yndigegn, T, Gudmundsdottir, I J, Koul, S, Sandhall, L, Danielewicz, M, Jakobsen, L, Olsson, S E, Olsson, H, Omerovic, E, Calais, F, Lindroos, P, Maeng, M, Venetsanos, D, James, S K, Kåregren, A, Carlsson, J, Jensen, J, Karlsson, A C, Erlinge, D & Fröbert, O 2022, ' 5-Year Outcomes of PCI Guided by Measurement of Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve ', Journal of the American College of Cardiology, vol. 79, no. 10, pp. 965-974 . https://doi.org/10.1016/j.jacc.2021.12.030
Background: Instantaneous wave-free ratio (iFR) is a coronary physiology index used to assess the severity of coronary artery stenosis to guide revascularization. iFR has previously demonstrated noninferior short-term outcome compared to fractional f
Autor:
Troels Yndigegn, Bertil Lindahl, Joakim Alfredsson, Jocelyne Benatar, Lisa Brandin, David Erlinge, Urban Haaga, Claes Held, Pelle Johansson, Patric Karlström, Thomas Kellerth, Toomas Marandi, Katarina Mars, Annica Ravn-Fischer, Johan Sundström, Ollie Östlund, Robin Hofmann, Tomas Jernberg
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy.
Aims Most trials showing benefit of beta-blocker treatment after myocardial infarction (MI) included patients with large MIs and are from an era before modern biomarker-based MI diagnosis and reperfusion treatment. The aim of the randomized evaluatio
Autor:
Kerstin Welén Schef, Per Tornvall, Joakim Alfredsson, Emil Hagström, Annica Ravn-Fischer, Stefan Soderberg, Troels Yndigegn, Tomas Jernberg
Publikováno v:
Heart. :heartjnl-2023
ObjectiveTo assess the contemporary prevalence of, and factors associated with angina pectoris symptoms, and to examine the relationship to coronary atherosclerosis in a middle-aged, general population.MethodsData were based on the Swedish CArdioPulm
Autor:
Divan Ishak, Suleman Aktaa, Lars Lindhagen, Joakim Alfredsson, Tatendashe Bernadette Dondo, Claes Held, Tomas Jernberg, Troels Yndigegn, Chris P Gale, Gorav Batra
Publikováno v:
Heart. :heartjnl-2022
ObjectiveBeta-blockers (BB) are an established treatment following myocardial infarction (MI). However, there is uncertainty as to whether BB beyond the first year of MI have a role in patients without heart failure or left ventricular systolic dysfu